Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AgelessRx vs MedLeanRx

By GLP-1 ScorecardUpdated

AgelessRx
Site position #17

Higher score

MedLeanRxFactor scores not reassessed.
Site position #73

Lower score

Score comparison

AgelessRx has the higher recorded score — 84.3/100 to 73.9/100.

AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Conventional and microdose GLP-1 programs with continuing care; branded prescriptions involve a separate pharmacy payment.

Before you choose

AgelessRx does not publish a semaglutide price, so its AgelessRx review sets out what it does disclose, while the MedLeanRx review explains the conditions attached to MedLeanRx's figure. The semaglutide cost page compares published rates across the field. Ask AgelessRx for a written total before treating either one as the cheaper choice.

If neither one fits, AgelessRx vs MEDVidi and Allara Health vs MedLeanRx compare each of them with another graded program, and the list of alternatives to AgelessRx ranks the programs closest to AgelessRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the bmiMD review covers one graded close to these two, at 79.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueAgelessRx +16
90
74
Dose & formulationMedLeanRx +13
80
93
Clinical oversightAgelessRx +6
83
77
Labs & monitoringAgelessRx +30
82
52
FulfillmentAgelessRx +7
84
77
Contract termsAgelessRx +30
85
55
AgelessRx · top barMedLeanRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAgelessRxMedLeanRx
WeighScore84.3/10073.9/100
GradeBC
Site position#17#73
SemaglutideNot verified (current medication-specific quote required)From $149/mo advertised for compounded semaglutide; confirm selected quote
TirzepatideMicrodose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote required$269 listed on the injection card; confirm charge and term
CoverageAdvertises US service; confirm treatment-specific state availabilityTexas program
Brand-name accessYesYes
Oral / sublingualYesYes
AgelessRx

Site position #17 · B

Strengths

  • Conventional and lower-dose GLP-1 programs advertised
  • Wegovy pens and oral-tablet consultations advertised
  • Continuing messaging and check-ins advertised

What to consider

  • Conventional medication-specific monthly quotes not verified
  • Microdose introduction renews as a two-month charge
  • Branded medication has a separate pharmacy bill
  • Treatment-specific state eligibility and assigned dispenser need confirmation
MedLeanRx

Site position #73 · C

Factor scores not reassessed.

Strengths

  • Separates semaglutide vial and tablet listings
  • Identifies the medication as a separate charge on the Wegovy pill card

What to consider

  • Starting prices depend on the prescribed product and dose
  • The terms exclude refunds for listed fees and services already rendered
  • Confirm the next charge and the dispensing pharmacy before paying

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard